It is time to develop appropriate tools for assessing minimal clinically important differences, performance bias and quality of evidence in reviews of behavioral interventions

We cannot ignore bias, especially if effects are small, but we need better methods for evaluating prevention systems

(2016) David R. Foxcroft   ADDICTION

Is it time for a more ambitious research agenda for decreasing alcohol-related harm among young adults?

(2016) Katharine A. Bradley et al.   ADDICTION

Is it time to define minimally clinically important differences for patient-reported outcome measures used in alcohol brief intervention studies?

(2016) Amanda S. Newton et al.   ADDICTION

Back to basics

(2016) Antoni Gual   ADDICTION

Users identified challenges in applying GRADE to complex interventions and suggested an extension to GRADE

(2016) Ani Movsisyan et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Commentary on Gelberget al. 2015: Alcohol and other drug screening and brief intervention - evidence in crisis

(2015) Richard Saitz   ADDICTION

Development, inter-rater reliability and feasibility of a checklist to assess implementation (Ch-IMP) in systematic reviews: the case of provider-based prevention and treatment programs targeting children and youth

(2015) Margaret Cargo et al.   BMC Medical Research Methodology

A New Taxonomy for Stakeholder Engagement in Patient-Centered Outcomes Research

(2012) Thomas W. Concannon et al.   JOURNAL OF GENERAL INTERNAL MEDICINE